AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30241766 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based parent stress intervention plus nutrition and physical activity counseling (PMH+N)
Number of subjects: 42
Study 30241766 — intervention group
Group type: COMPARATOR
Intervention: Control group intervention plus nutrition and physical activity counseling (C+N)
Number of subjects: 42
Study 27502862 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1180
Study 27502862 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1180
Study 24193163 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP of 8 cm H2O
Number of subjects: 16
Study 24193163 — intervention group
Group type: COMPARATOR
Intervention: PEEP of 5 cm H2O
Number of subjects: 16
Study 24193163 — intervention group
Group type: COMPARATOR
Intervention: PEEP of 2 cm H2O
Number of subjects: 16
Study 23089085 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance based mirror exposure therapy (A-MET)
Number of subjects: 33
Study 23089085 — intervention group
Group type: COMPARATOR
Intervention: Non-directive body image therapy (ND)
Number of subjects: 33
Study 20715729 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg) and tropisetron
Number of subjects: 14
Study 20715729 — intervention group
Group type: COMPARATOR
Intervention: Tropisetron alone
Number of subjects: 14
Study 18234407 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive motion (bouncing in the experimenter's arms for infants, and adults bouncing in synchrony with the experimenter)
Number of subjects: 0
Study 18234407 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement of the head
Number of subjects: 0
Study 18234407 — intervention group
Group type: COMPARATOR
Intervention: Movement of the legs
Number of subjects: 0
Study 15932956 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed rest with resistive vibration exercise (BR-RVE)
Number of subjects: 16
Study 15932956 — intervention group
Group type: COMPARATOR
Intervention: Bed rest control (BR-Ctrl)
Number of subjects: 16
Study 15932956 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BR-Ctrl and BR-RVE)
Number of subjects: 16
Study 12496542 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic totally extraperitoneal hernioplasty (TEP)
Number of subjects: 299
Study 12496542 — intervention group
Group type: COMPARATOR
Intervention: Open operation with mesh-plug
Number of subjects: 299
Study 12496542 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein's operation
Number of subjects: 299
Study 11144934 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily administration of valproate delayed release mini-tablets (VPA mrt.)
Number of subjects: 11
Study 11144934 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily administration of valproate delayed release mini-tablets (VPA mrt.)
Number of subjects: 11
Study 11144934 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with valproate delayed release mini-tablets (VPA mrt.)
Number of subjects: 11
Study 8783689 — intervention group
Group type: EXPERIMENTAL
Intervention: C. difficile-associated diarrhea
Number of subjects: 40
Study 8783689 — intervention group
Group type: COMPARATOR
Intervention: Diarrhea not associated with C. difficile
Number of subjects: 40
Study 8783689 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic colonization
Number of subjects: 40
Study 8783689 — intervention group
Group type: COMPARATOR
Intervention: Noncolonized controls without diarrhea
Number of subjects: 40
Study 8783689 — intervention group
Group type: EXPERIMENTAL
Intervention: Diarrhea presence
Number of subjects: 40
Study 8783689 — intervention group
Group type: EXPERIMENTAL
Intervention: C. difficile presence
Number of subjects: 40
Study 1459268 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrashort regimen of gonadotropin-releasing hormone agonist (GnRH-a)
Number of subjects: 48
Study 1459268 — intervention group
Group type: COMPARATOR
Intervention: Short regimen of gonadotropin-releasing hormone agonist (GnRH-a)
Number of subjects: 48
Study 6321310 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg X 2/day/7 days)
Number of subjects: 6
Study 6321310 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg X 2/day/7 days)
Number of subjects: 6
Study 6321310 — intervention group
Group type: COMPARATOR
Intervention: No pre-treatment
Number of subjects: 6
Study 31971089 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU daily for 4 weeks)
Number of subjects: 32
Study 31495242 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermapen (microneedling)
Number of subjects: 60
Study 31495242 — intervention group
Group type: EXPERIMENTAL
Intervention: Jessner's solution peeling
Number of subjects: 60
Study 31495242 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermapen and Jessner's solution peeling
Number of subjects: 60
Study 30145120 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer screening using low-dose CT with model incorporating nodule features and patient characteristics
Number of subjects: 9728
Study 26836927 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg three times a week for 8 weeks)
Number of subjects: 44
Study 26836927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 26836927 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin in patients with asthma
Number of subjects: 44
Study 24990972 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing cast with a Böhler iron
Number of subjects: 84
Study 24990972 — intervention group
Group type: COMPARATOR
Intervention: Non-weight-bearing cast
Number of subjects: 84
Study 22792314 — intervention group
Group type: EXPERIMENTAL
Intervention: Benfotiamine
Number of subjects: 82
Study 22792314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 19910336 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (ACT)
Number of subjects: 13
Study 18330080 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (TAM) 20 mg/m2/day orally
Number of subjects: 99
Study 18330080 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) plus 13-cis-retinoic acid (RA) 1 mg/kg/day orally
Number of subjects: 99
Study 18330080 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) plus Interferon alpha-2a (IFN alpha-2a) 3 MU thrice a week intramuscular
Number of subjects: 99
Study 16307267 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Evaluation and Management Unit (GEMU)
Number of subjects: 254
Study 16307267 — intervention group
Group type: COMPARATOR
Intervention: General Medical Wards (MW)
Number of subjects: 254
Study 11895347 — intervention group
Group type: EXPERIMENTAL
Intervention: Staples for skin closure
Number of subjects: 0
Study 11895347 — intervention group
Group type: COMPARATOR
Intervention: Sutures for skin closure
Number of subjects: 0
Study 9485067 — intervention group
Group type: EXPERIMENTAL
Intervention: [11C]raclopride-PET
Number of subjects: 18
Study 8595082 — intervention group
Group type: EXPERIMENTAL
Intervention: Test preparation T (10 mg nifedipine)
Number of subjects: 16
Study 8595082 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation R (20 mg nifedipine)
Number of subjects: 16
Study 2404477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling (reduced calories)
Number of subjects: 841
Study 2404477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling (reduced sodium)
Number of subjects: 841
Study 2404477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling (reduced sodium and calories)
Number of subjects: 841
Study 2404477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counseling (reduced sodium and increased potassium)
Number of subjects: 841
Study 2404477 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary counseling)
Number of subjects: 841
Study 327749 — intervention group
Group type: EXPERIMENTAL
Intervention: Stilbestrol treatment
Number of subjects: 2
Study 327749 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 2
Study 31804698 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 IU Botulinum toxin type A (BTX‐A)
Number of subjects: 60
Study 31804698 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 IU Botulinum toxin type A (BTX‐A)
Number of subjects: 60
Study 31004357 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia group
Number of subjects: 17
Study 31004357 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study 29029278 — intervention group
Group type: EXPERIMENTAL
Intervention: Delafloxacin 300mg administered intravenously twice daily for 5-14 days
Number of subjects: 660
Study 29029278 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 15mg/kg plus aztreonam 2g administered intravenously twice daily for 5-14 days
Number of subjects: 660
Study 29029278 — intervention group
Group type: EXPERIMENTAL
Intervention: Delafloxacin
Number of subjects: 660
Study 29029278 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin/aztreonam
Number of subjects: 660
Study 25454611 — intervention group
Group type: EXPERIMENTAL
Intervention: MRA+Forum
Number of subjects: 142
Study 25454611 — intervention group
Group type: COMPARATOR
Intervention: Forum
Number of subjects: 142
Study 25454611 — intervention group
Group type: COMPARATOR
Intervention: MRA Only
Number of subjects: 142
Study 23800196 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized plaque control (powered tooth brushing and inter-dental cleaning advice)
Number of subjects: 82
Study 23800196 — intervention group
Group type: COMPARATOR
Intervention: Usual plaque control regimen (Control)
Number of subjects: 82
Study 23800196 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized plaque control
Number of subjects: 82
Study 20798653 — intervention group
Group type: EXPERIMENTAL
Intervention: RMET + EN
Number of subjects: 26
Study 20798653 — intervention group
Group type: COMPARATOR
Intervention: EN alone
Number of subjects: 26
Study 20798653 — intervention group
Group type: EXPERIMENTAL
Intervention: R+EN
Number of subjects: 26
Study 20798653 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study 19920781 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab (n=113)
Number of subjects: 222
Study 19920781 — intervention group
Group type: COMPARATOR
Intervention: rATG (n=109)
Number of subjects: 222
Study 19920781 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab and rATG
Number of subjects: 222
Study 16731888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound consultation (including standard screen with extended consultation on fetal development, maternal and familial responses, and maternal‐fetal interaction)
Number of subjects: 52
Study 16731888 — intervention group
Group type: COMPARATOR
Intervention: Standard care (standard clinical ultrasound screen)
Number of subjects: 52
Study 12798637 — intervention group
Group type: EXPERIMENTAL
Intervention: C4-V3 polypeptide vaccine emulsified in incomplete Freund's
Number of subjects: 3189
Study 12798637 — intervention group
Group type: COMPARATOR
Intervention: Other vaccines and adjuvants studied
Number of subjects: 3189
Study 10476340 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenalectomy for hyperaldosteronism
Number of subjects: 0
Study 8724153 — intervention group
Group type: EXPERIMENTAL
Intervention: Multizone PRK
Number of subjects: 169
Study 8724153 — intervention group
Group type: COMPARATOR
Intervention: Monozone PRK
Number of subjects: 169
Study 1680150 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg oral folic acid
Number of subjects: 25
Study 1680150 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 25
Study 6336928 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% lactate lotion
Number of subjects: 60
Study 6336928 — intervention group
Group type: COMPARATOR
Intervention: 5% lactic acid lotion
Number of subjects: 60
Study 6336928 — intervention group
Group type: COMPARATOR
Intervention: Nonlactated emollient lotion
Number of subjects: 60
Study 30975730 — intervention group
Group type: EXPERIMENTAL
Intervention: MyStay multimedia intervention
Number of subjects: 241
Study 29255811 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose (SM) after 1 week (1W)
Number of subjects: 30
Study 29255811 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose (SM) after 6 months (6M)
Number of subjects: 30
Study 29255811 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (CF) after 1 week (1W)
Number of subjects: 30
Study 29255811 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (CF) after 6 months (6M)
Number of subjects: 30
Study 29255811 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (UN) after 1 week (1W)
Number of subjects: 30
Study 29255811 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (UN) after 6 months (6M)
Number of subjects: 30
Study 26912003 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg/day for 7 days, then 400 mg/day for 7 days)
Number of subjects: 120
Study 26912003 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivalent number of placebo tablets for 14 days)
Number of subjects: 120
Study 26912003 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone
Number of subjects: 120
Study 25085076 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with docetaxel, cisplatin, and 5‐fluorouracil (TPF)
Number of subjects: 232
Study 25085076 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with surgery and postoperative radiation
Number of subjects: 232
Study 22559839 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/Formoterol
Number of subjects: 2250
Study 22559839 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone/Salmeterol
Number of subjects: 2250
Study 19246607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone with glucometer (Diabetes Phone)
Number of subjects: 69
Study 19246607 — intervention group
Group type: COMPARATOR
Intervention: Internet-based glucose monitoring system (IBGMS)
Number of subjects: 69
Study 19246607 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 69
Study 17855695 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity exercise for 60 min per day, 6 days per week for 12 months
Number of subjects: 202
Study 14684569 — intervention group
Group type: EXPERIMENTAL
Intervention: OM triple (omeprazole, amoxycillin, and clarithromycin)
Number of subjects: 231
Study 14684569 — intervention group
Group type: COMPARATOR
Intervention: OM only (continuation of omeprazole)
Number of subjects: 231
Study 11772284 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0
Study 11772284 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0
Study 11772284 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins (general)
Number of subjects: 0
Study 11772284 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 0
Study 10225541 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix proteins (EMP)
Number of subjects: 16
Study 10225541 — intervention group
Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR) with bioabsorbable membranes
Number of subjects: 16
Study 7872184 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 103
Study 2592888 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer screening intervention
Number of subjects: 0
Study 2592888 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment methods for socio-economic status
Number of subjects: 0
Study 2592888 — intervention group
Group type: EXPERIMENTAL
Intervention: Future studies with socio-economic outcomes
Number of subjects: 0
Study 768533 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine-diphenoxylate (Lomotil)
Number of subjects: 200
Study 768533 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-phenacetin-caffeine (APC) plus codeine
Number of subjects: 200
Study 768533 — intervention group
Group type: COMPARATOR
Intervention: Lincomycin hydrochloride
Number of subjects: 200
Study 28396005 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access (TRA) procedures
Number of subjects: 562
Study 28396005 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous femoral access procedure
Number of subjects: 562
Study 25321149 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Spirit intervention plus optimized standard care
Number of subjects: 322
Study 25321149 — intervention group
Group type: COMPARATOR
Intervention: Optimized standard care alone
Number of subjects: 322
Study 23321385 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucromalt
Number of subjects: 44
Study 23321385 — intervention group
Group type: COMPARATOR
Intervention: Glucose (Dextrose)
Number of subjects: 44
Study 20868370 — intervention group
Group type: EXPERIMENTAL
Intervention: Child and Family Traumatic Stress Intervention (CFTSI)
Number of subjects: 176
Study 20868370 — intervention group
Group type: COMPARATOR
Intervention: Supportive Comparison condition
Number of subjects: 176
Study 19843482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg IV q6h
Number of subjects: 406
Study 19843482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg IV q6h
Number of subjects: 406
Study 19843482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study 18046889 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mucolytics (daily therapy for at least 2 months)
Number of subjects: 26
Study 18046889 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium and inhaled corticosteroids (ICS)
Number of subjects: 26
Study 18046889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucolytics
Number of subjects: 26
Study 14710215 — intervention group
Group type: EXPERIMENTAL
Intervention: 105-hour Psychological Training Program (PTP)
Number of subjects: 115
Study 14710215 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (Control Group)
Number of subjects: 115
Study 11377903 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 mm clear corneal incision (CCI)
Number of subjects: 168
Study 11377903 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5 mm sutured CCI
Number of subjects: 168
Study 11377903 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5 mm scleral tunnel
Number of subjects: 168
Study 8990451 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate, 1 mg/kg intramuscularly, within 24 hours postoperatively
Number of subjects: 129
Study 8990451 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 129
Study 8250455 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (streptokinase, urokinase, rt-PA) followed by balloon angioplasty
Number of subjects: 25
Study 8250455 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 25
Study 8250455 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 25
Study 8250455 — intervention group
Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 25
Study 8250455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no thrombolysis)
Number of subjects: 25
Study 3291526 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microgram dDAVP administered im every 12 h (N = 6)
Number of subjects: 15
Study 3291526 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 micrograms dDAVP administered im every 12 h (N = 5)
Number of subjects: 15
Study 3291526 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 micrograms dDAVP administered im every 12 h (N = 4)
Number of subjects: 15
Study 3291526 — intervention group
Group type: EXPERIMENTAL
Intervention: dDAVP treatment
Number of subjects: 15
Study 31793233 — intervention group
Group type: COMPARATOR
Intervention: ABA intervention delivered through face-to-face, telephone and text message by trained Infant Feeding Helpers (IFHs) from 30-weeks' gestation until 5-months postnatal.
Number of subjects: 103
Study 31793233 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 103
Study 31173739 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-guided (WFG) LASIK
Number of subjects: 100
Study 31173739 — intervention group
Group type: COMPARATOR
Intervention: Wavefront-optimized (WFO) LASIK
Number of subjects: 100
Study 28266875 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin-concomitant therapy for 10 days (n=55)
Number of subjects: 114
Study 28266875 — intervention group
Group type: COMPARATOR
Intervention: Sequential therapy (n=59)
Number of subjects: 114
Study 25442655 — intervention group
Group type: EXPERIMENTAL
Intervention: Early full weight bearing (11 days)
Number of subjects: 70
Study 25442655 — intervention group
Group type: COMPARATOR
Intervention: Standard full weight bearing (6 weeks)
Number of subjects: 70
Study 25442655 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 70
Study 25442655 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 70
Study 25442655 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with unstable type II fractures
Number of subjects: 70
Study 25442655 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with intact lateral hinges
Number of subjects: 70
Study 23906799 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent revascularization (ST)
Number of subjects: 0
Study 23906799 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise (SE)
Number of subjects: 0
Study 23906799 — intervention group
Group type: COMPARATOR
Intervention: Both ST and SE
Number of subjects: 0
Study 21259277 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 24
Study 21259277 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol succinate
Number of subjects: 24
Study 20135899 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antidepressants
Number of subjects: 0
Study 20135899 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 21355649 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-feedback intervention to promote positive parenting-child care (VIPP-CC)
Number of subjects: 48
Study 21355649 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48